Heel Fat Pad Syndrome

The VerdictMODERATE CONVICTION

Your heel's built-in shock absorber wore thin, so cushion it and stop pounding it, and never let anyone inject steroid into it.

Put a viscoelastic heel cup in the shoe you wear most, and stop walking barefoot on hard floors for two weeks. If the deep central heel ache eases with cushioning, that points to the fat pad, not plantar fasciitis.

Here's what's really happening: the pad that cushions your heel bone has degraded, so the bone loads a smaller, harder patch and it aches deep and central, worse barefoot on hard floors and later in the day.
The one thing that makes it worse: repeated steroid injections into the heel actually thin the pad and make this worse, so avoid them.
Start here: cushion and offload with a heel cup and softer shoes, ease off running and jumping, and get checked if you have diabetes.

Your heel bone sits on a memory-foam cushion made of fat in tiny walled pockets. Age, weight, and pounding break the walls so it squashes flat and stops bouncing back, and now the bone hammers the ground with every step. You cannot regrow the foam quickly, so the fix is to add cushioning back from the outside and take the pounding away while it settles.

What Works

Cinematic anatomy of the heel and its cushioning fat pad

Tier 1 — Strong Evidence NONE

There is no clinical guideline, no Cochrane review, and no adequately powered trial of a first-line treatment for this condition. A 2022 scoping review found the whole field is roughly seven studies.

Tier 2 — Cushion, Offload, and Do No Harm MODERATE

Cushion and offload. Viscoelastic heel cups or pads, cushioned or rocker-soled shoes, less barefoot walking on hard floors, and easing off high-impact loading. This is universally recommended and low-risk, but honestly it has never been tested in a trial.

Do not inject steroid. Repeated corticosteroid injection into the heel is one of the documented causes of fat pad atrophy. The shot can worsen the very problem.

Screen the drivers. Diabetes, rheumatoid arthritis, systemic sclerosis, and nerve disease all thin the pad. Treating the person, not just the heel, matters.

Exercise Prescription

This is a cushioning problem, not a weakness problem, so exercise supports the foot rather than fixing the pad. These are safe and worth doing.

Calf stretch — 3 × 30 seconds each leg, daily. Gentle stretch, no heel pain.

Foot "short foot" — 3 × 10 holds, daily. Draw the ball of the foot gently toward the heel without curling the toes.

Seated heel raises — 3 × 12, most days, progress to standing later. No sharp central heel pain.

See Tier 3 — Emerging / invasive options

Autologous fat grafting EMERGING — taking your own fat and grafting it into the pad. This holds the best-designed evidence in the whole field (a small randomized crossover, 13 patients, plus case series with durable heel benefit at nine years), but it is invasive and small. Reserved for recalcitrant, function-limiting cases after a real conservative trial.

Hyaluronic-acid filler injection EXPERIMENTAL — one short-term case series showed pain improvement at 24 weeks, but with adverse events including filler migration, and it is off-label for the foot.

What Doesn't Work

Repeated corticosteroid injections. They accelerate the atrophy that causes the pain.
Treating it as plantar fasciitis and stopping there. Fascia care half-treats a coexisting problem and misses the cushion entirely.
Ruling it out on a normal-thickness ultrasound. Thickness is an ambiguous marker and misses the loss of shock absorption.

Return to Training

Cut high-impact heel loading first (running on hard surfaces, jumping). Keep low-impact and upper-body work, and put a heel cup in your training shoes. Reintroduce impact last, and pain-gated. Tick these before full high-impact loading:

Pain-free full weight-bearing and walking on hard surfaces in cushioned footwear.
Can tolerate your target activity's heel loading at pain 3/10 or less, with no next-day flare.
No central heel tenderness on firm palpation.
Symptom-free or stable and manageable for 2 consecutive weeks.

Red Flags — When to Get Seen Urgently

Pain at night or at rest, especially with pain when you squeeze the sides of the heel bone. This can mean a stress fracture.
Both heels affected, or other joints/skin involved. Screen for diabetes, rheumatoid arthritis, systemic sclerosis, or nerve disease.
Diabetes or numb feet with any skin change, redness, or a sore on the heel. This is urgent, an ulcer-risk situation, not just pain.
A lump you can feel, or pain that keeps getting worse. Get it imaged to rule out a growth.
Burning, tingling, or numbness spreading into the foot. That points to a nerve, not the fat pad.

Refer to: GP or endocrinology for systemic-disease workup; orthopedics or podiatry for a suspected stress fracture, a mass, or a recalcitrant case; the urgent diabetic-foot pathway for any skin breakdown.

Put a viscoelastic heel cup in the shoe you wear most, and stop walking barefoot on hard floors for two weeks.

If that deep, central heel ache eases with cushioning, that points to the fat pad, not plantar fasciitis. It is a cushioning problem, so cushioning is the test and the first treatment.

Takes 2 minutes. One heel cup, no equipment.

Conviction MODERATE

The condition and its mechanism are on solid ground. Nearly every treatment number is not. First-line cushioning is sensible and low-risk but has never been trialed for how well or how long it works, and the only well-designed treatment study is an invasive fat graft in 13 patients.

What would change my mind — is cushioning actually the fix?

A real trial of a defined heel-cup protocol versus a sham insole, with proper foot pain and function scores AND a dynamic shock-absorption measure alongside static thickness, would finally tell us whether first-line cushioning works and whether it fixes thickness or bounce.

What would change my mind — is it thickness or shock absorption?

One in-vivo gait study found no thickness difference between painful and pain-free heels, only a loss of energy dissipation. If a larger study replicates that, the whole diagnosis should shift away from measuring thickness toward measuring how well the pad bounces back.

Go Deeper

Not sure whether your heel pain is the fascia, a nerve, or a worn-out cushion? The Verdict breaks down one evidence-based protocol every week, free.

Join The Verdict — free

The Full Picture — Anatomy, Diagnosis & Evidence

What's Actually Going On

Cinematic cross-section of the heel fat pad's chambered structure

The heel fat pad is not ordinary fat. It is a honeycomb of tightly packed, fat-filled chambers held in tough fibrous walls that anchor the skin to the heel bone. Under load it compresses, spreads the force over a broad area, and dissipates the impact instead of passing it to the bone.

In atrophy, that structure degrades. Under the microscope, atrophic pads show roughly 30% smaller fat cells and fibrous walls that are fragmented and about 75% wider than normal. The result is that a broad, low-pressure contact becomes a high, narrow peak of pressure right under the heel bone, and the pad loses its rebound.

The subtle point: the real deficit may not be thickness at all. A study measuring heel pads during walking found no difference in thickness between painful and pain-free heels, but the painful pads had clearly lost their shock-absorbing quality (energy dissipation 0.55 versus 0.69). A thick pad that no longer bounces can still hurt, and a resting scan cannot see that.

How to Identify It

Cinematic anatomy of the plantar heel under examination

There is no bedside test with published accuracy numbers for this condition. Diagnosis is clinical, corroborated imperfectly by ultrasound.

Deep, dull, bruise-like pain in the center of the heel, directly under the weight-bearing bone, not the inner arch.
Worse barefoot on hard or thin surfaces, better in cushioned shoes.
Worse with prolonged standing and as the day goes on, rather than the classic sharp first-step-in-the-morning pain of plantar fasciitis.
A pad that squashes flat and lets you feel the bone easily on pressing.

Central heel palpation Sn/Sp: DATA UNAVAILABLE and ultrasound thickness reliable to measure, ICC 0.78–0.98 are the workhorses, but ultrasound thickness is an imperfect and contested marker. A dynamic ultrasound scan catches the "clunk" of a subluxing fractured fat pad.

The Debate

Thickness vs. shock absorption

Some studies find a thinner pad in painful heels; the imaging meta-analysis finds a thicker loaded pad in heel pain; and the gait study finds no thickness difference at all, only lost energy dissipation. Thickness is a leaky proxy. A normal-thickness scan does not rule this out.

The evidence is upside-down

The best-designed treatment study is an invasive fat graft (a randomized crossover of 13 patients). The cheap, universally-recommended first-line cushioning has never been tested in a trial. The evidence landed where the researchers were, not where the best treatment is. There is no guideline for this condition as of 2026.

Honest Limitations

The whole field is tiny

A 2022 scoping review found about seven original studies and called the literature "sparse and sometimes lacking scientific rigor." Any confident protocol claim is running ahead of the data.

It gets confused with plantar fasciitis

Without agreed diagnostic criteria, fat pad studies and fasciitis studies contaminate each other, which is exactly why the evidence stays thin.

Cushioning is untested and adherence is hard

There is no trial for how well or how long heel cups work, and wearing an insert in every shoe is something people struggle to keep up. Make the cushioning easy to live with.

The Nuance

Cinematic anatomy illustrating the treatment decision for heel fat pad atrophy

Surgery here means adding tissue back, not fixing a bone. The conservative success rate has never actually been measured, because no trial has counted how many people respond to cushioning. The regenerative option, autologous fat grafting, showed significant pain and function gains versus offloading controls in the only randomized study (13 patients) and durable heel function at about nine years in a follow-up series.

The honest truth: the confident part of this condition is the anatomy and recognizing the pattern. The uncertain part is every treatment number. Most people should be managed conservatively, regenerative options held in reserve, and nobody should be getting repeated steroid injections into an atrophic heel.

Sources

Scoping review of heel fat pad syndrome, 2022, J Foot Ankle Res (PMID 35974398) — ~7 original studies; possibly the 2nd leading cause of plantar heel pain; no RCTs of heel cups/taping.
Bulk compressive properties of the heel pad during walking, 2009, Clin Biomech (PMID 19232452) — painful heels showed reduced energy dissipation (0.55 vs 0.69), not reduced thickness.
Autologous fat grafting for the heel (RCT crossover), 2021, Aesthet Surg J (PMID 33615336) — N=13; pain, function and appearance improved vs controls.
Histology of normal vs atrophic heel fat pad, 1995, Foot Ankle Int (PMID 7633580) — atrophic pads: ~30% smaller cells, ~75% wider fragmented walls.
Corticosteroid injection complications survey, 2011, Foot Ankle Int (PMID 21733442) — repeated steroid injection linked to heel fat pad atrophy.
Decreased subcalcaneal fat pad thickness and plantar heel pain, 2019, Pain Physician (PMID 30700074) — case-control N=375; thinner pad in the heel-pain group.